Quantcast
Last updated on April 23, 2014 at 21:24 EDT

Latest Interventional cardiology Stories

2013-10-29 23:18:51

Reportbuyer.com just published a new market research report: Global Cardiac Bio Implant Devices (Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Heart Valve, Coronary Stent, Peripheral Stent, Ventricular Assist Device) Market Forecast, Clinical Trials, M&A. London (PRWEB) October 29, 2013 The cardiac implant medical device market is forecasted to grow in single digit percent per year during 2010-2017 and is likely to exceed US$ 27 Billion by 2017. Growth in...

2013-10-29 20:22:14

Results of analysis of IVUS use in 8,582-patient, multicenter ADAPT-DES Study presented during oral session at 25th Annual TCT Scientific Symposium extend and confirm one-year findings SAN FRANCISCO, Oct. 29, 2013 /PRNewswire/ -- Volcano Corporation (NASDAQ: VOLC), a leading developer and manufacturer of precision guided tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, today announced new two-year outcomes from an analysis of use of...

2013-10-29 20:21:54

FARMINGTON, Mich., Oct. 29, 2013 /PRNewswire/ -- /Continental Who's Who/ -- Dr. Mark Rasak, MD is recognized by Continental Who's Who as a Pinnacle Professional in the field of Medicine as a result of his role as CEO of Cardiovascular Clinical Associates. Dr. Rasak has over 15 years of experience and specializes in managing all major aspects of the business; overseeing the daily operations; interventional cardiology; complex coronary angioplasty; as well as primary coronary...

2013-10-29 16:26:15

Company to Host Conference Call Tomorrow at 5:30 a.m. PT / 8:30 a.m. ET BOSTON, Oct. 29, 2013 /PRNewswire/ -- InspireMD, Inc. ("InspireMD" or the "Company") (NYSE MKT: NSPR), a leader in embolic protection stents, today announced new 12-month results from the MASTER (MGuard for Acute ST Elevation Reperfusion) trial demonstrating that the MGuard outperformed bare metal and drug eluting stents in all-cause mortality in ST segment elevation myocardial infarction (STEMI) patients....

2013-10-28 23:02:39

The Cardiac Catheterization Lab at The Mount Sinai Hospital Launches United States’ Use of Diamondback 360® Coronary Orbital Atherectomy System to Reduce Severe Arterial Calcium Prior to Cardiac Stents. New York, NY (PRWEB) October 28, 2013 Leading interventional cardiologists at The Mount Sinai Hospital are the first in the world to use a newly U.S. Food and Drug Administration (FDA) approved device for the treatment of severely calcified coronary arteries before the placement of...

2013-10-28 12:25:36

NATICK, Mass., Oct. 28, 2013 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will highlight the strength of its advanced portfolio and plans for delivering additional meaningful innovation to clinicians and patients through a robust schedule of sponsored research presentations at the 25(th) Annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation, October 27 - November 2 in San Francisco. The clinical...

2013-10-28 08:29:42

Agreement expands Philips' interventional cardiology portfolio ANDOVER AND BURLINGTON, Mass., Oct. 28, 2013 /PRNewswire/ -- Royal Philips (NYSE: PHG; AEX: PHIA) and Infraredx, Inc., a medical device company committed to advancing the diagnosis and management of coronary artery disease today announced a non-exclusive resale agreement for Infraredx's TVC Imaging System. Under the terms of the agreement, Philips will sell Infraredx's TVC Imaging System alongside its Allura...

2013-10-28 08:28:49

- Demonstrated Lack of Late Lumen Loss Progression Over 18 Months in Conjunction with Excellent Tissue Healing - DURHAM, N.C., Oct. 28, 2013 /PRNewswire/ -- Micell Technologies, Inc. today announced that imaging and clinical results from the DESSOLVE I and DESSOLVE II trials of its MiStent Sirolimus Eluting Absorbable Polymer Coronary Stent System (MiStent SES(®)) were presented at the 25th Annual Transcatheter Cardiovascular Therapeutics (TCT) Conference held in San...

2013-10-27 12:20:29

Company to have strong presence at TCT 2013 with new iFR/FFR data from ADVISE II and analysis of IVUS use in ADAPT-DES featured in scientific program SAN DIEGO, Oct. 27, 2013 /PRNewswire/ -- Volcano Corporation (NASDAQ: VOLC), a leading developer and manufacturer of precision guided tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, today announced several significant clinical data presentations and other activities related to its physiology and...

2013-10-26 23:01:57

RnRMarketResearch.com adds Latest Report on “Global Coronary Stents – Market Growth Analysis, 2009-2015” to its store. Global coronary stents industry forecasts to reach at US$7 billion by 2015 at a CAGR of 9.1% during the analysis period 2009-2015. Dallas, TX (PRWEB) October 26, 2013 The broad ‘health care’ division has been witnessing a rapid growth and technological improvements varying from sector to sector since the past 3-5 years. The evolution of cardiac devices has...


Latest Interventional cardiology Reference Libraries

Coronary Angiography
2013-07-29 11:05:01

A coronary angiography, also known as a coronary catheterization, is a procedure that gives both visual and tactical access to coronary circulation and blood filled chambers of the heart for both diagnostic and interventional purposes. It is one of many diagnostic tests used in cardiology. More specifically, coronary catheterization recognizes occlusion, stenosis, thrombosis or aneurismal enlargement of the walls of the coronary arteries; heart chamber size; heart muscle contraction...

More Articles (1 articles) »